On October 20, 2020, Anchiano Therapeutics Ltd. reconstituted the membership of the Audit Committee of the Board. Mr. Neil Cohen stepped down from the Audit Committee (as well as stepping down from the Compensation Committee and the Corporate Governance and Nominating Committee) in light of his new position as Chief Executive Officer of the Company. Ruth Alon, a current member of the Audit Committee, has been designated as the new Chair of the Audit Committee. Current Board member Isaac Kohlberg will join the Audit Committee.